JP2023545830A5 - - Google Patents
Info
- Publication number
- JP2023545830A5 JP2023545830A5 JP2023523244A JP2023523244A JP2023545830A5 JP 2023545830 A5 JP2023545830 A5 JP 2023545830A5 JP 2023523244 A JP2023523244 A JP 2023523244A JP 2023523244 A JP2023523244 A JP 2023523244A JP 2023545830 A5 JP2023545830 A5 JP 2023545830A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic composition
- composition according
- raav
- insect cells
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092179P | 2020-10-15 | 2020-10-15 | |
| US63/092,179 | 2020-10-15 | ||
| PCT/US2021/055243 WO2022082017A2 (en) | 2020-10-15 | 2021-10-15 | Recombinant adeno-associated virus compositions and methods for producing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545830A JP2023545830A (ja) | 2023-10-31 |
| JP2023545830A5 true JP2023545830A5 (enExample) | 2024-10-24 |
Family
ID=78819612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523244A Pending JP2023545830A (ja) | 2020-10-15 | 2021-10-15 | 組換えアデノ随伴ウイルス組成物及びその生産方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220119843A1 (enExample) |
| EP (1) | EP4229206A2 (enExample) |
| JP (1) | JP2023545830A (enExample) |
| KR (1) | KR20230088393A (enExample) |
| CN (1) | CN116710567A (enExample) |
| AU (1) | AU2021359852A1 (enExample) |
| CA (1) | CA3198675A1 (enExample) |
| IL (1) | IL302109A (enExample) |
| MX (1) | MX2023004420A (enExample) |
| WO (1) | WO2022082017A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120077057A (zh) | 2022-10-04 | 2025-05-30 | 伊莱利利公司 | Trem2相关疾病和病症的基因治疗 |
| AR131035A1 (es) | 2022-11-11 | 2025-02-12 | Lilly Co Eli | Ácidos nucleicos sintéticos que incluyen constructos promotores dirigidos a astrocitos y métodos de uso de los mismos |
| CN116350801A (zh) * | 2022-11-22 | 2023-06-30 | 四川至善唯新生物科技有限公司 | 一种重组腺相关病毒载体的药物组合物及其用途 |
| TW202432839A (zh) * | 2022-12-06 | 2024-08-16 | 美商再生元醫藥公司 | 用於確定病毒載體基因體滴度之液滴式數位ｐｃｒ分析 |
| WO2025190864A1 (en) * | 2024-03-11 | 2025-09-18 | Sartorius Stedim Biotech Gmbh | Improved cell lysis methods, reagents, and kits for viral vector release and production |
| WO2026043765A1 (en) | 2024-08-21 | 2026-02-26 | Eli Lilly And Company | Engineered regulatory splice elements for gene therapies |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1463805B1 (en) | 2001-12-17 | 2014-10-22 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| WO2007084773A2 (en) * | 2006-01-20 | 2007-07-26 | University Of North Carolina At Chapel Hill | Enhanced production of infectious parvovirus vectors in insect cells |
| EP3387138B2 (en) * | 2015-12-11 | 2026-05-27 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| CN106916793B (zh) * | 2015-12-24 | 2019-01-15 | 中国科学院武汉物理与数学研究所 | 一种重组腺相关病毒的制备方法及重组杆状病毒 |
| US20200316221A1 (en) * | 2016-10-13 | 2020-10-08 | University Of Massachusetts | Aav capsid designs |
| EP3692158A4 (en) * | 2017-10-03 | 2021-08-04 | Prevail Therapeutics, Inc. | GENE THERAPIES FOR LYSOSOMAL DISEASES |
| MX2020004005A (es) | 2017-10-03 | 2020-10-05 | Prevail Therapeutics Inc | Terapias genicas para los trastornos lisosomales. |
| CN111542549A (zh) | 2017-10-03 | 2020-08-14 | 普利维尔治疗公司 | 用于溶酶体障碍的基因疗法 |
| AU2018354195A1 (en) | 2017-10-23 | 2020-06-04 | Prevail Therapeutics, Inc. | Gene therapies for neurodegenerative disease |
| EP4585229A3 (en) * | 2017-11-08 | 2026-01-14 | Novartis AG | Means and method for preparing viral vectors and uses of same |
-
2021
- 2021-10-15 JP JP2023523244A patent/JP2023545830A/ja active Pending
- 2021-10-15 CN CN202180078052.9A patent/CN116710567A/zh active Pending
- 2021-10-15 AU AU2021359852A patent/AU2021359852A1/en active Pending
- 2021-10-15 MX MX2023004420A patent/MX2023004420A/es unknown
- 2021-10-15 CA CA3198675A patent/CA3198675A1/en active Pending
- 2021-10-15 WO PCT/US2021/055243 patent/WO2022082017A2/en not_active Ceased
- 2021-10-15 US US17/502,979 patent/US20220119843A1/en active Pending
- 2021-10-15 KR KR1020237015788A patent/KR20230088393A/ko active Pending
- 2021-10-15 EP EP21816205.5A patent/EP4229206A2/en active Pending
- 2021-10-15 IL IL302109A patent/IL302109A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6995006B2 (en) | Methods for generating high titer helper-free preparations of released recombinant AAV vectors | |
| US6566118B1 (en) | Methods for generating high titer helper-free preparations of released recombinant AAV vectors | |
| Qu et al. | Scalable downstream strategies for purification of recombinant adeno-associated virus vectors in light of the properties | |
| EP1009808B1 (en) | Methods for generating high titer helper-free preparations of recombinant aav vectors | |
| JP5268890B2 (ja) | Ａａｖの規模適応性の製造方法 | |
| US6593123B1 (en) | Large-scale recombinant adeno-associated virus (rAAV) production and purification | |
| JP7598333B2 (ja) | 組換えウイルスベクターの製造方法 | |
| JP2004508041A (ja) | 組換え型アデノ随伴ウイルス（ｒＡＡＶ）をパッケージングする親細胞、それらの生成方法、およびその使用 | |
| US20240084268A1 (en) | Method for purifying recombinant viral particles | |
| US20250059564A1 (en) | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer | |
| JP2024542950A5 (enExample) | ||
| CN120513301A (zh) | 纯化完全重组aav颗粒的方法 | |
| WO2005035743A1 (en) | Method for large-scale production, isolation, purification and the uses of multi-type recombinant adeno-associated virus vectors | |
| JP2025522718A (ja) | 組み換えウイルスの改善された発酵産生のための方法及びキット | |
| AU2022329857A1 (en) | Isolated modified aav9 capsid protein vp1 | |
| US20250382587A1 (en) | Methods for manufacturing viruses and viral particles | |
| AU2003204921B2 (en) | Methods for generating high titer helper-free preparations of recombinant AAV vectors | |
| WO2025065890A1 (zh) | 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用 | |
| WO2025238067A1 (en) | Novel vector system for aav production | |
| WO2026089607A1 (en) | Recombinant baculovirus with improved genetic stability | |
| CN117098841A (zh) | 用于纯化重组病毒颗粒的方法 | |
| AU2007205720A1 (en) | Methods for generating high titer helper-free preparations of recombinant AAV vectors |